… Arch Intern Med, 1993; 153:598-615 5) Yano K, Reed DM, and McGee DL: Ten-year
incidence of coronary heart disease in the Honolulu Heart Program: relationship to biologic and …

… and/or estimation of prognosis in patients with known coronary artery disease or the
assessment of patients with known or suspected valvular heart disease.) (Level of Evidence: C) …

… Heart Disease includes a section that focuses on management of older adults.18 The guideline
acknowledges that, although there is strong rationale to treat ischemic heart disease (IHD…

… in 4444 patients with coronary heart disease: the … Disease(LIPID) Study Group: Prevention
of cardiovascular events and death with pravastatin in patients with coronary heart disease …

… similar to the New York Heart Association functional and therapeutic classification of patients
with diseases of the heart framework. However, unlike heart disease, in which the primary …

… -acute pericardial disease. Advanced left heart disease progressing to right-sided failure
should also be considered, and similarly long-standing congenital heart disease with evolving …

… (AHA) Task Force on Practice Guidelines was formed to make recommendations regarding
the diagnosis and treatment of patients with known or suspected cardiovascular disease. …

… This executive summary highlights the evidence evaluation and treatment recommendations
of the 2010 evidence … Ischaemic heart disease is the leading cause of death in the world. …

… The study found that antioxidants had no apparent effect on heart disease. However, in
males, total cancers and incidence of mortality decreased by 31 and 38%, respectively. No such …

… to heart injury and/or dysfunction; CRS type 4 = chronic kidney disease leading to heart injury,
disease and/or … injury and/or dysfunction of heart and kidney. Different pathophysiological …